StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
133750.KQ$1400.00-0.43%
Fair $1400.00+0.0%

133750.KQ

MegaMD Co., Ltd.

Consumer Defensive / Education & Training ServicesKOSDAQ

$1400.00

-6.00 (-0.43%)

Fairly Valued+0.0%Fair Value $1400.00Fund rank 29/100 · Data gapFallback financials|
SA 35/D
F-Score: 4/9
Low Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 20%

FCF escenarios

weak_data · normalized FCF $3.8B · quality 52.7/100

Data gap 29/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 24/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

35/100

D

Piotroski

4/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 1unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified. ROE is 4.2%, below the 5% threshold
Thesis & Journal · 133750.KQLocal privado en este navegador · MegaMD Co., Ltd.
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$30.9B

P/E

N/A

•

EV/EBITDA

2.5x

↓

ROE

4.2%

↓

Gross Margin

59.5%

↑

Debt/Equity

0.05

↓
52-Week Range$1400
$1365$2280

TradingView lightweight chart

133750.KQ price, volumen y niveles de valoración

Último $1,400Periodo -63.2%
Fair value: $1,400

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

-18.7%

FCF CAGR

—

FCF margin

10.9%

FCF / Net income

1.35x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $34.59B · net income $2.79B · FCF $3.77B

2022-FY → 2025-FY

Gross margin

59.5%-1.0% pts

Operating margin

5.5%+1.4% pts

Net margin

8.1%+4.8% pts

FCF margin

10.9%+26.4% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$34.59B$34.59B$36.49B$36.04B$64.47B
Net Income$2.79B$2.79B$3.78B$-3.20B$2.11B
EBITDA$8.59B$8.59B$10.15B$3.02B$12.20B
EPS——171.00-145.0096.00
Gross Margin59.5%59.5%59.9%55.6%60.5%
Operating Margin5.5%5.5%6.3%-10.8%4.1%
Net Margin8.1%8.1%10.4%-8.9%3.3%
Balance Sheet
Debt/Equity0.050.050.070.080.11
Current Ratio2.002.00———
Cash Flow
Free Cash Flow$3.77B$3.77B$8.10B$-1.43B$-10.01B
Returns
ROE4.2%4.2%5.8%-5.1%3.2%
Valuation
P/E——12.95—30.21
EV/EBITDA2.542.542.3110.973.15
P/B0.470.470.740.930.97
Growth & Yield
Revenue Growth-5.2%-5.2%1.2%-44.1%—
EPS Growth——217.9%-251.0%—
Dividend Yield4.3%4.3%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -31.7%

Total return

-31.7%

Start / end P/E

n/dx → n/dx

EPS bridge

171.00 → n/d

Residual

-35.9%

EPS growthn/d
Multiple reratingn/d
Dividend+4.3%
Residual / FX / buybacks / cross-term-35.9%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.